{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:06:08Z","timestamp":1791979568488,"version":"4.4.0"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Antidotes play a crucial role in medical toxicology, providing life-saving interventions against a wide range of toxic substances. Despite their long-standing use, new evidence suggests that fomepizole,\n                      <jats:sc>l<\/jats:sc>\n                      -carnitine, and naloxone may have a wider range of applications than previously thought. This manuscript aims to review the emerging evidence for new treatment indications for fomepizole,\n                      <jats:sc>l<\/jats:sc>\n                      -carnitine, and naloxone.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A narrative literature review was conducted to inform clinicians and researchers about the evolving practices of antidote therapy and to identify areas where further research is warranted to optimize patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Fomepizole has proven its service in the treatment of toxic alcohol poisoning. The inhibitory action of fomepizole on the CYP2E1 and JNK pathways opens new avenues for its application as an antidote for a broader panel of intoxications, including paracetamol poisoning. In addition to\n                      <jats:sc>l<\/jats:sc>\n                      -carnitine supplementation to restore valproic acid\u2013induced carnitine deficiency after chronic use or overdose, many other benefits have been attributed to\n                      <jats:sc>l<\/jats:sc>\n                      -carnitine supplementation for the treatment of drug intoxication. The antioxidative effects of carnitine and its role in promoting fatty acid \u03b2-oxidation via the mass effect are less well established. Finally, naloxone is known for its antagonistic action in cases of opioid overdose. Regarding novel indications, the most compelling evidence for naloxone as an antidote was found for clonidine and angiotensin-converting enzyme inhibitors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      The repurposing of antidotes such as fomepizole,\n                      <jats:sc>l<\/jats:sc>\n                      -carnitine, and naloxone represents a promising frontier in precision toxicology. As the understanding of molecular toxicology deepens, it is becoming increasingly feasible to match antidotes to specific molecular signatures of toxicity, rather than relying solely on syndromic classifications.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001433","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T05:01:45Z","timestamp":1769403705000},"page":"172-184","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Beyond the Usual: Novel Therapeutic Roles for Established Antidotes"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1753-4637","authenticated-orcid":false,"given":"Arjen","family":"Koppen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7937-0343","authenticated-orcid":false,"given":"Marieke A.","family":"Dijkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8933-070X","authenticated-orcid":false,"given":"Corine C.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0191-7270","authenticated-orcid":false,"given":"Dylan W.","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"R1-20260313","doi-asserted-by":"crossref","first-page":"638057","DOI":"10.1155\/2013\/638057","article-title":"A systematic review of ethanol and fomepizole use in toxic alcohol ingestions","volume":"2013","author":"Beatty","year":"2013","journal-title":"Emerg Med Int"},{"key":"R2-20260313","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12967-025-06341-5","article-title":"Comprehensive review of the expanding roles of the carnitine pool in metabolic physiology: beyond fatty acid oxidation","volume":"23","author":"Xiang","year":"2025","journal-title":"J Transl Med"},{"key":"R3-20260313","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1056\/NEJMra1807054","article-title":"Prevention of opioid overdose","volume":"380","author":"Babu","year":"2019","journal-title":"N Engl J Med"},{"key":"R4-20260313","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00204-021-03211-z","article-title":"Comparing N-acetylcysteine and 4-methylpyrazole as antidotes for acetaminophen overdose","volume":"96","author":"Akakpo","year":"2022","journal-title":"Arch Toxicol"},{"key":"R6-20260313","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1056\/NEJMra1615295","article-title":"Toxic alcohols","volume":"378","author":"Kraut","year":"2018","journal-title":"N Engl J Med"},{"key":"R8-20260313","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.legalmed.2012.10.001","article-title":"Ethanol as a single toxin in non-traumatic deaths--a toxicology perspective","volume":"15","author":"Tormey","year":"2013","journal-title":"Leg Med (Tokyo)"},{"key":"R9-20260313","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/bcp.12824","article-title":"Antidotes for poisoning by alcohols that form toxic metabolites","volume":"81","author":"McMartin","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"R13-20260313","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/0091270008327142","article-title":"Fomepizole: a critical assessment of current dosing recommendations","volume":"49","author":"Bestic","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"R14-20260313","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0272-6386(00)70270-8","article-title":"Childhood diethylene glycol poisoning treated with alcohol dehydrogenase inhibitor fomepizole and hemodialysis","volume":"35","author":"Brophy","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R15-20260313","first-page":"A5240","article-title":"A patient with a life-threatening disulfiram-ethanol reaction","volume":"157","author":"Tummers-de Lind van Wijngaarden","year":"2013","journal-title":"Ned Tijdschr Geneeskd"},{"key":"R16-20260313","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/15563650.2019.1708091","article-title":"Fomepizole to treat disulfiram-ethanol reaction: a case series","volume":"58","author":"Schicchi","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"R17-20260313","doi-asserted-by":"crossref","first-page":"262.e3","DOI":"10.1016\/j.ajem.2010.11.014","article-title":"Fomepizole for severe disulfiram-ethanol reactions","volume":"30","author":"Sande","year":"2012","journal-title":"Am J Emerg Med"},{"key":"R18-20260313","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1177\/0960327118774902","article-title":"4-Methylpyrazole protects against acetaminophen hepatotoxicity in mice and in primary human hepatocytes","volume":"37","author":"Akakpo","year":"2018","journal-title":"Hum Exp Toxicol"},{"key":"R19-20260313","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0041-008X(89)90287-1","article-title":"Effect of ethanol on hepatotoxicity of acetaminophen in mice and on reactive metabolite formation by mouse and human liver microsomes","volume":"100","author":"Thummel","year":"1989","journal-title":"Toxicol Appl Pharmacol"},{"key":"R20-20260313","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0196-0644(94)70067-2","article-title":"4-Methylpyrazole blocks acetaminophen hepatotoxicity in the rat","volume":"23","author":"Brennan","year":"1994","journal-title":"Ann Emerg Med"},{"key":"R21-20260313","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00210-008-0343-2","article-title":"Ruthenium red protects HepG2 cells overexpressing CYP2E1 against acetaminophen cytotoxicity","volume":"379","author":"Holownia","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R22-20260313","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1006\/bbrc.2002.6541","article-title":"Reduction of toxic metabolite formation of acetaminophen","volume":"291","author":"Hazai","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"R23-20260313","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13181-021-00862-3","article-title":"Analysis of fomepizole elimination in Methanol- and ethylene glycol-poisoned patients","volume":"18","author":"McMartin","year":"2022","journal-title":"J Med Toxicol"},{"key":"R24-20260313","doi-asserted-by":"crossref","first-page":"117666","DOI":"10.1016\/j.ejmech.2025.117666","article-title":"Discovery of a CYP2E1 inhibitor and its therapeutic potential in severe acute pancreatitis","volume":"292","author":"Qiu","year":"2025","journal-title":"Eur J Med Chem"},{"key":"R25-20260313","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1124\/dmd.116.070193","article-title":"Selective Time- and NADPH-dependent inhibition of human CYP2E1 by clomethiazole","volume":"44","author":"Stresser","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"R26-20260313","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/gut.2006.104372","article-title":"Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure","volume":"56","author":"Henderson","year":"2007","journal-title":"Gut"},{"key":"R27-20260313","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/toxsci\/kfz077","article-title":"Delayed treatment with 4-methylpyrazole protects against acetaminophen hepatotoxicity in mice by inhibition of c-Jun n-Terminal kinase","volume":"170","author":"Akakpo","year":"2019","journal-title":"Toxicol Sci"},{"key":"R28-20260313","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1007\/s00204-021-03142-9","article-title":"Delayed administration of N-acetylcysteine blunts recovery after an acetaminophen overdose unlike 4-methylpyrazole","volume":"95","author":"Akakpo","year":"2021","journal-title":"Arch Toxicol"},{"key":"R29-20260313","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/bcp.15201","article-title":"Large paracetamol overdose-higher dose acetylcysteine is required","volume":"89","author":"Bateman","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"R30-20260313","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/MJT.0b013e3181ff7ac0","article-title":"A gargantuan acetaminophen level in an acidemic patient treated solely with intravenous N-acetylcysteine","volume":"20","author":"Zell-Kanter","year":"2013","journal-title":"Am J Ther"},{"key":"R31-20260313","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/15563650.2016.1144889","article-title":"Potential adjunct treatment for high-risk acetaminophen overdose","volume":"54","author":"Yip","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"key":"R32-20260313","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.toxrep.2021.03.031","article-title":"Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy","volume":"8","author":"Cuninghame","year":"2021","journal-title":"Toxicol Rep"},{"key":"R34-20260313","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/24734306.2019.1705596","article-title":"Use of fomepizole as an adjunct in the treatment of acetaminophen overdose: a case series","volume":"4","author":"Rampon","year":"2020","journal-title":"Toxicol Commun"},{"key":"R35-20260313","doi-asserted-by":"crossref","first-page":"410.e5","DOI":"10.1016\/j.ajem.2019.09.005","article-title":"Fomepizole as an adjunctive treatment in severe acetaminophen toxicity","volume":"38","author":"Shah","year":"2020","journal-title":"Am J Emerg Med"},{"key":"R36-20260313","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/15563650.2020.1775847","article-title":"Fomepizole as an adjunctive treatment in severe acetaminophen ingestions: a case series","volume":"59","author":"Shah","year":"2021","journal-title":"Clin Toxicol (Phila)"},{"key":"R37-20260313","doi-asserted-by":"crossref","first-page":"692.e5","DOI":"10.1016\/j.ajem.2019.09.026","article-title":"Use of fomepizole, n-acetylcysteine, and hemodialysis for massive acetaminophen overdose","volume":"38","author":"Woolum","year":"2020","journal-title":"Am J Emerg Med"},{"key":"R38-20260313","first-page":"6695967","article-title":"Massive acetaminophen overdose treated successfully with N-acetylcysteine, fomepizole, and hemodialysis","volume":"2021","author":"Chiu","year":"2021","journal-title":"Case Rep Crit Care"},{"key":"R39-20260313","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/15563650.2021.1996591","article-title":"Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series","volume":"60","author":"Link","year":"2022","journal-title":"Clin Toxicol (Phila)"},{"key":"R40-20260313","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/138920011796504536","article-title":"L-carnitine-metabolic functions and meaning in humans life","volume":"12","author":"Pekala","year":"2011","journal-title":"Curr Drug Metab"},{"key":"R41-20260313","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1743-7075-7-30","article-title":"Role of carnitine in disease","volume":"7","author":"Flanagan","year":"2010","journal-title":"Nutr Metab (Lond)"},{"key":"R42-20260313","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1124\/pharmrev.121.000408","article-title":"Acylcarnitines: nomenclature, biomarkers, therapeutic potential, drug targets, and clinical trials","volume":"74","author":"Dambrova","year":"2022","journal-title":"Pharmacol Rev"},{"key":"R43-20260313","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bcp.16233","article-title":"l-carnitine for valproic acid-induced toxicity","volume":"91","author":"Gziut","year":"2025","journal-title":"Br J Clin Pharmacol"},{"key":"R44-20260313","doi-asserted-by":"crossref","first-page":"7890","DOI":"10.3390\/ijms21217890","article-title":"Organic cation transporters in human physiology, pharmacology, and toxicology","volume":"21","author":"Samodelov","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R45-20260313","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","article-title":"Carnitine transport and fatty acid oxidation","volume":"1863","author":"Longo","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"R46-20260313","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/2472555218812821","article-title":"OCTN: a small transporter subfamily with great relevance to human pathophysiology, drug discovery, and diagnostics","volume":"24","author":"Pochini","year":"2019","journal-title":"SLAS Discov"},{"key":"R47-20260313","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2165\/00003088-200342110-00002","article-title":"Pharmacokinetics of l-carnitine","volume":"42","author":"Evans","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"R48-20260313","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40262-017-0506-8","article-title":"Renal drug transporters and drug interactions","volume":"56","author":"Ivanyuk","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"R49-20260313","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0022-3565(24)35167-5","article-title":"Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance","volume":"291","author":"Ohashi","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"R51-20260313","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s13181-013-0301-3","article-title":"l-Carnitine for the treatment of a calcium channel blocker and metformin poisoning","volume":"9","author":"St-Onge","year":"2013","journal-title":"J Med Toxicol"},{"key":"R52-20260313","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1553-2712.2011.01217.x","article-title":"l-carnitine increases survival in a murine model of severe verapamil toxicity","volume":"18","author":"Perez","year":"2011","journal-title":"Acad Emerg Med"},{"key":"R53-20260313","doi-asserted-by":"crossref","first-page":"tfae104","DOI":"10.1093\/toxres\/tfae104","article-title":"l-carnitine: a novel approach in management of acute cholinesterase inhibitor insecticide poisoning","volume":"13","author":"Ragab","year":"2024","journal-title":"Toxicol Res (Camb)"},{"key":"R54-20260313","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/toxres\/tfad035","article-title":"The therapeutic benefit of antioxidants on the outcome of acute aluminum phosphide poisoning: a systemic review and meta-analysis","volume":"12","author":"Sobh","year":"2023","journal-title":"Toxicol Res (Camb)"},{"key":"R55-20260313","doi-asserted-by":"crossref","first-page":"9603271221149650","DOI":"10.1177\/09603271221149650","article-title":"Comparing the effectiveness of l-carnitine and paraffin oil in acute aluminum phosphide poisoning using predictive biomarkers and scores: a randomized controlled clinical trial","volume":"42","author":"Abdelhamid","year":"2023","journal-title":"Hum Exp Toxicol"},{"key":"R56-20260313","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13054-025-05330-w","article-title":"Sodium azide (NaN(3)) intoxication, \u201cthe man who lived\u201d: potential effective antidote and treatment strategy","volume":"29","author":"Geerdink","year":"2025","journal-title":"Crit Care"},{"key":"R57-20260313","first-page":"739","article-title":"The impact of l-carnitine administration on the serum level of myocardium injury markers in patients with acute carbon monoxide poisoning","volume":"23","author":"Sun","year":"2011","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"R58-20260313","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.taap.2018.11.007","article-title":"Clozapine-induced reduction of l-carnitine reabsorption via inhibition\/down-regulation of renal carnitine\/organic cation transporter 2 contributes to liver lipid metabolic disorder in mice","volume":"363","author":"Wang","year":"2019","journal-title":"Toxicol Appl Pharmacol"},{"key":"R59-20260313","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/toxres\/tfaa002","article-title":"Efficacy of L-carnitine and propranolol in the management of acute theophylline toxicity","volume":"9","author":"Sherif","year":"2020","journal-title":"Toxicol Res (Camb)"},{"key":"R60-20260313","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.freeradbiomed.2022.06.244","article-title":"Inhibition of the carnitine acylcarnitine carrier by carbon monoxide reveals a novel mechanism of action with non-metal-containing proteins","volume":"188","author":"Tonazzi","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"R62-20260313","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40262-024-01355-6","article-title":"Clinical pharmacokinetics and pharmacodynamics of naloxone","volume":"63","author":"Saari","year":"2024","journal-title":"Clin Pharmacokinet"},{"key":"R63-20260313","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41386-022-01416-z","article-title":"Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade","volume":"48","author":"Trostheim","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"R64-20260313","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.drugalcdep.2017.05.001","article-title":"Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-conception and maturation","volume":"178","author":"McDonald","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"R68-20260313","doi-asserted-by":"crossref","first-page":"1346109","DOI":"10.3389\/fpubh.2024.1346109","article-title":"Fact versus fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids","volume":"12","author":"Dahan","year":"2024","journal-title":"Front Public Health"},{"key":"R69-20260313","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0196-0644(05)81389-7","article-title":"Naloxone reversal of hypotension due to captopril overdose","volume":"20","author":"Varon","year":"1991","journal-title":"Ann Emerg Med"},{"key":"R71-20260313","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMra1202561","article-title":"Management of opioid analgesic overdose","volume":"367","author":"Boyer","year":"2012","journal-title":"N Engl J Med"},{"key":"R72-20260313","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/15563650.2016.1253846","article-title":"Do heroin overdose patients require observation after receiving naloxone?","volume":"55","author":"Willman","year":"2017","journal-title":"Clin Toxicol (Phila)"},{"key":"R73-20260313","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/15563650.2025.2504133","article-title":"Nitazenes: review of comparative pharmacology and antagonist action","volume":"63","author":"Stangeland","year":"2025","journal-title":"Clin Toxicol (Phila)"},{"key":"R75-20260313","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1017\/S0963180121000116","article-title":"The birth of naloxone: an intellectual history of an ambivalent opioid","volume":"30","author":"Kolbe","year":"2021","journal-title":"Camb Q Healthc Ethics"},{"key":"R76-20260313","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0140-6736(81)91308-8","article-title":"Behavioural effects after high dose naloxone administration to normal volunteers","volume":"2","author":"Cohen","year":"1981","journal-title":"Lancet"},{"key":"R78-20260313","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3109\/15563650.2011.609823","article-title":"A novel use of naloxone as a treatment for eucalyptus oil induced central nervous system depression","volume":"49","author":"Doshi","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"key":"R79-20260313","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-3940(01)02527-7","article-title":"Menthol: a natural analgesic compound","volume":"322","author":"Galeotti","year":"2002","journal-title":"Neurosci Lett"},{"key":"R80-20260313","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.pain.2013.06.043","article-title":"TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain","volume":"154","author":"Liu","year":"2013","journal-title":"Pain"},{"key":"R81-20260313","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/15563650.2018.1450986","article-title":"Naloxone reversal of clonidine toxicity: dose, dose, dose","volume":"56","author":"Seger","year":"2018","journal-title":"Clin Toxicol (Phila)"},{"key":"R82-20260313","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/bph.12695","article-title":"Analgesic synergy between opioid and \u03b12-adrenoceptors","volume":"172","author":"Chabot-Dore","year":"2015","journal-title":"Br J Pharmacol"},{"key":"R83-20260313","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0196-0644(81)80257-0","article-title":"Naloxone administration in clonidine overdosage","volume":"10","author":"North","year":"1981","journal-title":"Ann Emerg Med"},{"key":"R84-20260313","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/jpc.16399","article-title":"Reality of clonidine poisoning in children and adolescents","volume":"59","author":"Duong","year":"2023","journal-title":"J Paediatr Child Health"},{"key":"R86-20260313","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1080\/15563650.2020.1863977","article-title":"High dose naloxone for acute tizanidine overdose in the emergency department: a case report","volume":"59","author":"Adams","year":"2021","journal-title":"Clin Toxicol (Phila)"},{"key":"R87-20260313","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12245-021-00397-y","article-title":"Pediatric tizanidine toxicity reversed with naloxone: a case report","volume":"14","author":"Bader","year":"2021","journal-title":"Int J Emerg Med"},{"key":"R88-20260313","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s43678-024-00808-y","article-title":"Continuous naloxone infusion for the treatment of guanfacine toxicity in a 2-year-old male","volume":"27","author":"Gilbert","year":"2025","journal-title":"CJEM"},{"key":"R89-20260313","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/PEC.0b013e31826ce9f1","article-title":"Treatment of guanfacine toxicity with naloxone","volume":"28","author":"Tsze","year":"2012","journal-title":"Pediatr Emerg Care"},{"key":"R91-20260313","first-page":"87551225251326811","article-title":"Standard instructions and counseling for naloxone insufficient in the era of xylazine and medetomidine adulteration of illicit opioids","author":"Datta","year":"2025","journal-title":"J Pharm Technol"},{"key":"R93-20260313","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/tjem.tjem_198_22","article-title":"A case series of accidental xylazine intoxication in humans; is there a role of naloxone as an antidote?","volume":"23","author":"Choon","year":"2023","journal-title":"Turk J Emerg Med"},{"key":"R94-20260313","first-page":"e40983","article-title":"The new stealth drug on the street: a narrative review of xylazine as a street drug","volume":"15","author":"Pergolizzi","year":"2023","journal-title":"Cureus"},{"key":"R95-20260313","first-page":"e57638","article-title":"The management of xylazine overdose with naloxone","volume":"16","author":"Morris","year":"2024","journal-title":"Cureus"},{"key":"R96-20260313","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jemermed.2022.12.010","article-title":"Use of naloxone in angiotensin-converting enzyme inhibitor overdose: a case report","volume":"64","author":"Haluska","year":"2023","journal-title":"J Emerg Med"},{"key":"R97-20260313","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1007\/s12630-020-01680-x","article-title":"Naloxone as an antidote for angiotensin converting enzyme inhibitor poisoning: a case report","volume":"67","author":"Trivedi","year":"2020","journal-title":"Can J Anaesth"},{"key":"R98-20260313","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1440-1681.1983.tb00192.x","article-title":"Attenuation of the antihypertensive effect of captopril by the opioid receptor antagonist naloxone","volume":"10","author":"Millar","year":"1983","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R99-20260313","doi-asserted-by":"crossref","first-page":"1217.e1","DOI":"10.1016\/j.ajem.2019.03.046","article-title":"Angiotensin converting enzyme inhibitor intoxication: naloxone to the rescue? Naloxone for ACE inhibitor intoxication","volume":"37","author":"Robert","year":"2019","journal-title":"Am J Emerg Med"},{"key":"R100-20260313","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2125.1984.tb02408.x","article-title":"The influence of naloxone on the circulatory effects of captopril","volume":"17","author":"Rubin","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"R101-20260313","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.emc.2022.01.008","article-title":"The roles of antidotes in emergency situations","volume":"40","author":"Kaiser","year":"2022","journal-title":"Emerg Med Clin North Am"},{"key":"R102-20260313","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/toxics11090723","article-title":"Antidotes in clinical toxicology-critical review","volume":"11","author":"Kobylarz","year":"2023","journal-title":"Toxics"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:00:42Z","timestamp":1773378042000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001433","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"2025-07-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}